中国呼吸与危重监护杂志

中国呼吸与危重监护杂志

  1. 期刊首页
  2. 期刊简介
  3. 投稿指南
  4. 在线期刊
  5. 本刊动态
  6. 期刊订阅
  7. 联系我们

慢性阻塞性肺疾病患者血清 CTRP5 的含量变化及临床意义

解小云 1 , 宋艳红 2 , , 于雪梅 2 , 荣淑慧 2 , 刘景彬 2 , 刘兰香 3 , 续丽杰 3

1. 内蒙古医科大学（内蒙古包头  014032） ;
2. 内蒙古医科大学第四附属医院呼吸科（内蒙古包头  014032） ;
3. 内蒙古医科大学第四附属医院体检中心（内蒙古包头  014032）

收稿日期: 2017-03-23;  修回日期:2017-08-17; 

基金项目: 包头市卫生基金项目（wsjj2016071）

通讯作者: 宋艳红, Email: songyanhong369@163.com

The changes and clinical significance of serum complement C1q tumor necrosis factor related protein 5 in patients with chronic obstructive pulmonary disease

XIE Xiaoyun 1 , SONG Yanhong 2 , , YU Xuemei 2 , RONG Shuhui 2 , LIU Jingbin 2 , LIU Lanxiang 3 , XU Lijie 3

1. Inner Mongolia Medical University, Baotou, Inner Mongolia 014032, P. R. China ;
2. Department of Respiratory Medicine, The Fourth Affiliated Hospital of Inner Mongolia Medical University, Baotou, Inner Mongolia 014032, P. R. China ;
3. Department of Medical Examination Center, The Fourth Affiliated Hospital of Inner Mongolia Medical University, Baotou, Inner Mongolia 014032, P. R. China

Corresponding Author: SONG Yanhong, Email: songyanhong369@163.com

查看全文

目的研究慢性阻塞性肺疾病（简称慢阻肺）患者急性加重期和稳定期外周血清中补体 C1q 肿瘤坏死因子相关蛋白 5（complement C1q tumor necrosis factor related protein 5，CTRP5）的含量变化及其与超敏 C 反应蛋白（high sensitivity C-reactive protein，hs-CRP）、第 1 秒用力呼气容积占用力肺活量百分比（FEV1/FVC）、第 1 秒用力呼气容积占预计值百分比（FEV1%pred）的相关性。方法连续收集我院呼吸科住院和门诊符合纳入标准的慢阻肺急性加重期和稳定期患者各 30 例，选择同时间在我院体检中心体检的健康者 30 名为正常对照组。测定三组研究对象血清 CTRP5 和 hs-CRP 的含量，并进行肺功能检查，测定 FEV1/FVC 和 FEV1%pred。结果急性加重期组血清 CTRP5、hs-CRP 含量均高于稳定期组和正常对照组，稳定期组均高于正常对照组。急性加重期组与稳定期组 FEV1/FVC 均低于正常对照组，急性加重期组亦低于稳定期组。三组 FEV1%pred 差异存在统计学意义，进一步比较，急性加重期组和稳定期组差异无统计学意义，且两组均低于正常对照组。无论急性加重期组还是稳定期组，CTRP5 与 hs-CRP 均呈正相关，CTRP5 与 FEV1/FVC、FEV1%pred 值均呈负相关。结论慢阻肺患者血清中 CTRP5、hs-CRP 的含量增高，不同时期 CTRP5 均与 hs-CRP 呈正相关，与 FEV1/FVC、FEV1%pred 呈负相关。提示 CTRP5 参与慢阻肺的炎症发病的全过程，但确切机制仍需进一步研究。

ObjectiveTo explore the serum concentrations of complement C1q tumor necrosis factor related protein 5 (CTRP5) in patients with acute exacerbations and stable stage of chronic obstructive pulmonary disease (COPD), and analyze the correlation of CTRP5 with high sensitivity C-reactive protein (hs-CRP) and FEV1/FVC and FEV1%pred.MethodsThirty hospitalized patients with acute exacerbation of COPD and 30 outpatients with stable COPD according with diagnostic criteria and inclusive criteria were sampled successively. At the same time 30 healthy volunteers were selected as normal control. All subjects were measured the concentrations of CTRP5 and hs-CRP in serum and lung function test was performed.ResultsThe serum CTRP5 and hs-CRP concentrations of the acute exacerbation group was higher than those in the stable group and the control group. The serum CTRP5 and hs-CRP concentrations of the stable group was also higher than those of the control group. The FEV1/FVC of the acute exacerbation group was lower than those of the stable group and the control group; and the FEV1/FVC of the stable group was lower than that of the control group. The FEV1%pred of three groups by analysis indicated the difference was statistically significant. Further pairwise comparisons demonstrated that the FEV1%pred of two COPD groups were lower than that of the control group but the FEV1%pred of the acute exacerbation group and stable group was not significantly different. The correlation analysis of the acute exacerbation group and the stable group demonstrated that the levels of serum CTRP5 and hs-CRP were postively correlated and the level of serum CTRP5 was negatively correlated with FEV1/FVC and FEV1%pred.ConclusionsThe level of CTRP5 in serum of COPD patients is increased. No matter in acute exacerbation or stable phase, the level of serum CTRP5 is positively correlated with hs-CRP and negatively correlated with FEV1/FVC and FEV1%pred, which suggests that CTRP5 is involved in the pathogenesis of COPD but the exact mechanism needs further study.

关键词: 慢性阻塞性肺疾病; 补体 C1q 肿瘤坏死因子相关蛋白 5; 超敏 C 反应蛋白; 第 1 秒用力呼气容积

Key words: Chronic obstructive pulmonary disease; Complement C1q tumor necrosis factor related protein 5; High sensitivity C-reactive protein; Forced expiratory volume in one second

引用本文： 解小云, 宋艳红, 于雪梅, 荣淑慧, 刘景彬, 刘兰香, 续丽杰. 慢性阻塞性肺疾病患者血清 CTRP5 的含量变化及临床意义. 中国呼吸与危重监护杂志, 2018, 17(2): 113-118. doi: 10.7507/1671-6205.201703036 复制

登录后 ，请手动点击刷新查看全文内容。 没有账号，
登录后 ，请手动点击刷新查看图表内容。 没有账号，
1. 中华医学会呼吸病学分会慢性阻塞性肺病学组, 慢性阻塞性肺疾病诊治指南 (2013 修订).中华结核和呼吸杂志, 2013, 36(4): 255-264.
2. Li D, Wu Y, Tian P, et al. Adipokine CTRP-5 as a Potential Novel Inflammatory Biomarker in Chronic Obstructive Pulmonary Disease. Medicine (Baltimore), 2015, 94(3): e1503.
3. Assad NA, Sood A. Leptin, adiponectin and pulmonary diseases. Biochimie, 2012, 94, (10): 2180-2189.
4. 宋艳红, 荣淑慧, 李维才, 等. 脂联素在慢性阻塞性肺疾病不同分期的表达.中国呼吸与危重监护杂志, 2014, 13(3): 237-240.
5. Eker S, Ayaz L, Tamer L, et al. Leptin, visfatin, insulin resistance, and body composition change in chronic obstructive pulmonary disease. Scand J Clin Lab Invest., 2010, 70 (1): 40-44.
6. 雷虹, 张洁, 王瑾瑜, 等.补体 C1q/肿瘤坏死因子相关蛋白家族研究进展.生理科学进展, 2015, 46(1): 43-48.
7. Schmid A, Kopp A, Aslanidis C, et al. Regulation and Function of C1Q/TNF-related Protein-5(CTRP-5) in the Context of Adipocyte Biology.Exp Clin Endocrinol Diabetes, 2013, 121(5): 310-317.
8. 毛燕青, 李苏, 王翎, 等.血清超敏 C 反应蛋白和前白蛋白在老年 COPD 患者中的变化.中国老年学杂志, 2010, 30(19): 2713-2725.
9. Higashimoto Y, Iwata T, Okada M, et al. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Respir Med, 2009, 103(8): 1231-1238.
10. Karadag F, Kirdar S, Karul AB, et al. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Eur J Intern Med, 2008, 19(2): 104-108.
11. Park S-Y, Choi JH, Ryu HS, et al. C1q tumor necrosis factor alpha-related protein isoform 5 is increased in mitochondrial DNA-depleted myocytes and activates AMP-activated protein kinase. J Biol Chem, 2009, 284(41): 27780-27789.
12. Sin DD, Man SF, Systemic inflammation and mortality in chronic obstructive pulmonary disease. Can J PhysiolPharmacol, 2007, 85(1): 141-147.
13. Remels AH, Gosker HR, Schrauwen P, et al.TNF-alpha impairs regulation of muscle oxidative phenotype: implications for cachexia?. FASEB J, 2010, 24(12): 5052-5062.
14. Yang W-M, Lee W. CTRP-5 ameliorates palmitate-induced apoptosis and insulin resistance through activation of AMPK and fatty acid oxidation. BiochemBiophysRes Commun, 2014, 452(3): 715-721.
15. Zhang P, Cao M, Liu Y, et al. PDGF-induced airway smooth muscle proliferation is associated with Human antigen R activation and could be weakened by AMPK activation. Mol Biol Rep, 2012, 39(5): 5819-5829.